Pharmacology Related Content

Elif Engin, PhD, grew up in Ankara, Turkey, and earned her undergraduate and master’s degrees at Middle East Technical University (METU) in Ankara. She completed her doctoral work in the laboratory of Dr. Dallas Treit in Edmonton, Alberta, and was awarded a PhD Thesis Award from the Canadian...

Jing Liu, PhD, received his PhD degree in medicinal chemistry from the Academy of Military Medical Sciences in China. He has accumulated over 12 years of research experience in medicinal chemistry, especially in drug research and development. Dr. Liu has been a post-doctoral fellow at McLean...

A career investigator of the NIMH from 1970 to 2001, Ross J. Baldessarini, MD, is an internationally known research psychopharmacologist with many contributions to the actions of antipsychotic and mood-altering medicines and has trained over 160 laboratory and clinical investigators. He joined...

Carol A. Paronis, PhD, is director of the Laboratory of Preclinical Pharmacology at McLean Hospital and an associate professor of psychiatry at Harvard Medical School. Dr. Paronis received her PhD in pharmacology from Emory University and completed post-doctoral fellowships in pharmacology at the...

Laura Erwin, PhD, is a post-doctoral research fellow in the Preclinical Pharmacology Program at McLean Hospital. Her research focuses on elucidating the pharmacological mechanisms and neurobiology that mediate the behavioral effects of drug of misuse. Dr. Erwin received her PhD at LSU Health...

Scott E. Lukas received his PhD in pharmacology and toxicology in 1979 from the University of Maryland. After a post-doctoral fellowship at Johns Hopkins University, he joined NIDA Addiction Research Center for 18 months before moving to McLean in 1984. Promoted to professor in 2003, Dr. Lukas...

Stephen J. Kohut, PhD, focuses his research primarily on two main interacting lines of investigation: understanding how alterations in underlying neurobiology alter behavioral responses to drugs, especially stimulants and opioids, and medications discovery for drug misuse and addiction. Dr. Kohut’s...

J. Alexander Bodkin, MD, has been at McLean since 1985. Working with Dr. Jonathan Cole until his death, Dr. Bodkin has long pursued the study of new and old medications for depression and anxiety. His research has focused on underutilized pharmacologic approaches to difficult-to-treat mood and...

Brian D. Kangas, PhD, is an assistant professor of psychiatry at Harvard Medical School and director of the Translational Behavioral Pharmacology Laboratory at McLean Hospital. He first studied behavioral pharmacology while completing his PhD under the direction of Dr. Marc Branch at the University...

Rajeev I. Desai, PhD, is an associate professor of psychiatry at Harvard Medical School and director of the Integrative Neurochemistry Laboratory at McLean Hospital. Dr. Desai received his PhD in psychology/behavioral pharmacology at the University of Birmingham, U.K. He completed post-doctoral...